KENILWORTH, NJ-Merck & Co. is reported to be exploring various possibilities for sale and re-use of its manufacturing buildings here as it completes consolidation of plant activities out-of-state.
The company told njbiz.com that it is discussing sales with both private companies and government agencies, but did not disclose details. Read more here.
Merck will officially close operations at the buildings Oct. 1.
The drugmaker did officially notify the state Labor Department July 26 that it will lay off 113 employees at its Galloping Hill Road plant, as has been expected. The pill-making operations have mostly already moved to other facilities, but Merck says research work will continue at the Kenilworth location.
Merck acquired the Kenilworth properties three years ago with its acquisition of Schering-Plough. Merck currently has its headquarters in Whitehouse Station, but will move to Summit in 2015.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
